Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Outstanding
Ratios

Elicio Therapeutics (ELTX) Other Gross PP&E Adjustments (2020 - 2026)

Elicio Therapeutics filings provide 4 years of Other Gross PP&E Adjustments readings, the most recent being -$5.6 million for Q4 2023.

  • On a quarterly basis, Other Gross PP&E Adjustments fell 5.7% to -$5.6 million in Q4 2023 year-over-year; TTM through Dec 2023 was -$5.6 million, a 5.7% decrease, with the full-year FY2023 number at -$5.6 million, down 5.7% from a year prior.
  • Other Gross PP&E Adjustments hit -$5.6 million in Q4 2023 for Elicio Therapeutics, roughly flat from -$5.5 million in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of -$126000.0 in Q1 2023 to a low of -$6.1 million in Q4 2021.
  • Median Other Gross PP&E Adjustments over the past 4 years was -$3.9 million (2021), compared with a mean of -$3.9 million.
  • The widest YoY moves for Other Gross PP&E Adjustments: up 95.54% in 2023, down 129.19% in 2023.
  • Elicio Therapeutics' Other Gross PP&E Adjustments stood at -$4.8 million in 2020, then dropped by 26.49% to -$6.1 million in 2021, then rose by 13.6% to -$5.3 million in 2022, then decreased by 5.7% to -$5.6 million in 2023.
  • The last three reported values for Other Gross PP&E Adjustments were -$5.6 million (Q4 2023), -$5.5 million (Q3 2023), and -$5.5 million (Q2 2023) per Business Quant data.